Court Place Advisors, LLC Biogen Inc. Transaction History

Court Place Advisors, LLC

$307 Million
Q4 2024

A detailed history of Court Place Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Court Place Advisors, LLC holds 5,688 shares of BIIB stock, worth $674,653. This represents 0.28% of its overall portfolio holdings.

Number of Shares

5,688

Previous 8,601 33.87%

Holding current value

$674,653

Previous $1.67 Million 47.87%

% of portfolio

0.28%

Previous 0.49%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$146.47 - $191.55 $426,667 - $557,985	-2,913 Reduced 33.87%	5,688 $869,000
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $1.15 Million - $1.44 Million	6,079 Added 241.04%	8,601 $1.67 Million
Q3 2024 Oct 23, 2024	SELL	$189.07 - $236.8 $1.26 Million - $1.57 Million	-6,651 Reduced 72.51%	2,522 $488,000
Q2 2024 Jul 31, 2024	SELL	$190.52 - $236.72 $2,857 - $3,550	-15 Reduced 0.16%	9,173 $2.13 Million
Q1 2024 Apr 26, 2024	SELL	$212.02 - $267.71 $272,445 - $344,007	-1,285 Reduced 12.27%	9,188 $1.98 Million
Q4 2023 Jan 31, 2024	SELL	$222.59 - $267.94 $36,282 - $43,674	-163 Reduced 1.53%	10,473 $2.71 Million
Q3 2023 Nov 01, 2023	SELL	$253.3 - $285.89 $27,863 - $31,447	-110 Reduced 1.02%	10,636 $2.73 Million
Q2 2023 Aug 01, 2023	SELL	$275.25 - $318.06 $99,090 - $114,501	-360 Reduced 3.24%	10,746 $3.06 Million
Q1 2023 May 08, 2023	SELL	$256.56 - $292.34 $120,583 - $137,399	-470 Reduced 4.06%	11,106 $3.09 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $11,359 - $13,802	-45 Reduced 0.39%	11,576 $3.21 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $58,991 - $81,343	-303 Reduced 2.54%	11,621 $3.1 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $14,065 - $16,726	-75 Reduced 0.63%	11,924 $2.43 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $277,091 - $349,120	-1,430 Reduced 10.65%	11,999 $2.53 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $316,398 - $406,619	-1,413 Reduced 9.52%	13,429 $3.22 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $5,659 - $7,381	-20 Reduced 0.13%	14,842 $4.2 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $7,770 - $12,441	-30 Reduced 0.2%	14,862 $5.15 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $51,019 - $59,772	-210 Reduced 1.39%	14,892 $4.17 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $70,878 - $106,689	-300 Reduced 1.95%	15,102 $3.7 Million
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $15,886 - $18,342	-60 Reduced 0.39%	15,402 $4.37 Million
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $10,346 - $13,702	-40 Reduced 0.26%	15,462 $4.14 Million
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $33,606 - $42,630	-125 Reduced 0.8%	15,502 $4.91 Million
Q4 2019 Jan 28, 2020	BUY	$220.06 - $304.07 $60,956 - $84,227	277 Added 1.8%	15,627 $4.64 Million
Q3 2019 Oct 22, 2019	SELL	$217.44 - $243.88 $93,281 - $104,624	-429 Reduced 2.72%	15,350 $3.57 Million
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $20,832 - $22,963	95 Added 0.61%	15,779 $3.69 Million
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $117,023 - $183,038	540 Added 3.57%	15,684 $3.71 Million
Q4 2018 Jan 28, 2019	BUY	$278.5 - $352.75 $165,986 - $210,239	596 Added 4.1%	15,144 $4.56 Million
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $54,079 - $64,451	-210 Reduced 1.42%	14,548 $4.22 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $163,881 - $231,783	630 Added 4.46%	14,758 $4.04 Million
Q4 2017 Jan 30, 2018	SELL	$307.64 - $344.58 $12,305 - $13,783	-40 Reduced 0.28%	14,128 $4.5 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $3.98 Million - $4.67 Million	14,168	14,168 $4.44 Million

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

127M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Court Place Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Court Place Advisors, LLC with notifications on news.

Account

Court Place Advisors, LLC Biogen Inc. Transaction History